MedTrace Logo

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

NCT00185887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2011-03-08

No results posted yet for this study

Summary

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Conditions

  • Fetal Distress

Interventions

DRUG

Terbutaline

Terbutaline 250 micrograms intravenously for intrapartum fetal resuscitation. Nitroglycerine 400 micrograms intravenously for intrapartum fetal resuscitation.

Sponsors & Collaborators

Principal Investigators

  • Yasser Yehia El-Sayed · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2006-07-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00185887 on ClinicalTrials.gov